CN113173896A - Ferulic acid derivative with antioxidant activity and preparation method thereof - Google Patents
Ferulic acid derivative with antioxidant activity and preparation method thereof Download PDFInfo
- Publication number
- CN113173896A CN113173896A CN202110402623.1A CN202110402623A CN113173896A CN 113173896 A CN113173896 A CN 113173896A CN 202110402623 A CN202110402623 A CN 202110402623A CN 113173896 A CN113173896 A CN 113173896A
- Authority
- CN
- China
- Prior art keywords
- ferulic acid
- reaction
- solution
- andrographolide
- silica gel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/60—Two oxygen atoms, e.g. succinic anhydride
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
Abstract
The invention provides a ferulic acid derivative with antioxidant activity and a preparation method thereof, wherein the ferulic acid derivative comprises the following steps: andrographolide is dissolved in an organic solvent, ferulic acid is added, ferulic acid derivatives with a novel structure are formed through esterification, the new compounds have a good clearance rate on DPPH free radicals, the highest clearance rate reaches 94.22 percent and is higher than that of vitamin C (90.48 percent) under the same concentration, and the ferulic acid derivatives have the potential and significance for preparing new anti-oxidation active drugs. The preparation method provided by the invention is simple, the raw materials are easy to obtain, the yield is high, the operation condition is mild, the ferulic acid derivative can be conveniently prepared, and the preparation method is suitable for industrial production.
Description
Technical Field
The invention belongs to the technical field of chemical drug synthesis, and relates to a ferulic acid derivative with antioxidant activity and a preparation method thereof.
Background
Ferulic acid has strong antioxidant activity, because ferulic acid has strong scavenging effect on hydrogen peroxide, superoxide radical, hydroxyl radical and peroxynitrite radical, on the other hand, ferulic acid can inhibit enzyme generating free radical and promote the generation of antioxidant enzyme. Researches show that the ferulic acid derivative also has better antioxidant activity, for example, Zhang Qiang and the like (research on antioxidant activity of ferulic acid Poria cocos polysaccharide, modern food science and technology, (27)9, 2011) combines ferulic acid with Poria cocos to synthesize the ferulic acid Poria cocos polysaccharide compound.
Disclosure of Invention
One object of the present invention is to provide an antioxidant ferulic acid derivative having the molecular structure of formula (I):
another object of the present invention is to provide a method for preparing ferulic acid derivatives with antioxidant activity, comprising the following steps:
(1) dissolving andrographolide in an anhydrous organic solvent A, slowly adding oxalyl chloride at the temperature of-10-0 ℃, adding 2-3 drops of DMF (N, N-dimethylformamide), raising the temperature to react for 2-5 h, and removing redundant oxalyl chloride to obtain a compound 1 after the reaction is finished;
(2) dissolving the compound 1 in an organic solvent B, adding ferulic acid, stirring at room temperature for reaction for 4-8 h, and displaying no progress of the reaction by thin-layer chromatography. Adding sodium bicarbonate solution into the reaction solution, extracting with dichloromethane or ethyl acetate, washing the organic phase with saturated saline solution and 5% hydrochloric acid solution in sequence, drying, concentrating, and eluting and purifying the crude product with silica gel column to obtain andrographolide derivatives.
In the preparation method, in the step (1), the organic solvent A is one, two, three or more of dichloromethane, diethyl ether, tetrahydrofuran, benzene and toluene;
the mass/volume ratio of the andrographolide to the organic solvent A is 1: 3-5 g/mL;
the feeding molar ratio of the andrographolide to the oxalyl chloride is 1: 3-7;
the reaction temperature is 40-80 ℃.
In the preparation method, in the step (2), the dosage of the ferulic acid is 50-70% of the dosage of the compound 1;
the solvent B is chloroform, acetone, dioxane, a mixed solvent of chloroform and acetone in a volume ratio of 1:1 or a mixed solvent of chloroform and dioxane in a volume ratio of 1: 1;
the filler of the chromatographic column in the silica gel column chromatography is 100-400 meshes of silica gel; the mass ratio of the crude product sample to the silica gel is 1: 20-50; adopting a wet method for sample loading, and dissolving the crude product sample in a low-polarity solvent selected from ether, petroleum ether or n-hexane to obtain a loaded sample;
the eluent is a mixed solution of n-hexane and ethyl acetate, and the volume ratio of the n-hexane to the ethyl acetate is 5: 1-10: 1.
Compared with the prior art, the invention has the beneficial effects that:
the ferulic acid derivative provided by the invention has a better clearance rate on DPPH free radicals, the highest clearance rate reaches 94.22 percent and is higher than that of vitamin C (90.48 percent) under the same concentration, which indicates that the ferulic acid derivative has the potential and significance for preparing novel anti-oxidation active medicaments. The preparation method provided by the invention is simple, good in repeatability, good in stability, easy in obtaining of raw materials, high in yield, mild in operation condition, capable of conveniently preparing the andrographolide derivative and suitable for industrial production.
Drawings
FIG. 1: nuclear magnetic resonance hydrogen spectrum of the antioxidant active ferulic acid derivative of example 1.
Detailed Description
The present invention will be described in further detail with reference to specific embodiments for the purpose of making the objects, technical solutions and advantages of the present invention more apparent, but it should not be construed that the scope of the above-described subject matter of the present invention is limited to the following examples.
Example 1
(1) Adding 20g of andrographolide into 60mL of anhydrous dichloromethane, refluxing and dissolving for 30min, slowly adding 21.7g of oxalyl chloride at the temperature of-10-0 ℃, stirring for 30min, adding 2-3 drops of DMF (N, N-dimethylformamide), raising the temperature to 40 ℃, reacting for 2h, and removing excessive oxalyl chloride by rotary evaporation to obtain a compound 1 after the reaction is finished.
(2) Dissolving 15g of the compound 1 in 100mL of chloroform, adding 7.5g of ferulic acid, stirring at room temperature for reaction for 4h, wherein thin-layer chromatography shows that the reaction does not progress, adding a sodium bicarbonate solution into a reaction solution, extracting with dichloromethane (3X 0.5L), washing an organic phase with a saturated saline solution and a 5% hydrochloric acid solution in sequence, drying with anhydrous sodium sulfate, and concentrating to obtain a crude product; dissolving the crude product with low-polarity ether, stirring the crude product with 100-400-mesh silica gel to obtain a sample, wherein the mass ratio of the crude product to the silica gel is 1:20, separating and purifying the sample on the silica gel column, eluting impurities with an eluant consisting of n-hexane and ethyl acetate according to the volume ratio of 5:1, collecting the eluant, and concentrating to obtain the andrographolide derivative.
Experimental example 2 antioxidant Activity test of the derivative of the present invention
DPPH is a very stable nitrogen-centered radical that traps ("scavenges") other radicals, has a strong absorption at 520nm, and its alcohol solution is purple in color. When a radical scavenger is added to the DPPH solution, it enables the pairing of single electrons, thereby enabling A520nmThe value is reduced, the solution becomes light in color and yellow or light yellow, the change degree of the solution and the free radical scavenging degree are in a linear relation, so the method can be used for expressing the scavenging rate, and the higher the scavenging rate is, the stronger the scavenging capacity of the substance is.
Preparation of DPPH solution: accurately weighing 20mg of DPPH, dissolving with absolute ethyl alcohol, and metering the volume to a 500mL brown volumetric flask to obtain 0.004 percent DPPH solution, and storing in dark for later use.
Preparation of sample and reference solution: the derivative derivatives of example 1 were precisely weighed, dissolved in water, to a volume of 10mL, diluted, and dispensed into 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7mg/mL solutions, to prepare four sample solutions. In the same manner, vitamin C sample solution (control group 1), andrographolide sample solution (control group 2), ferulic acid sample solution (control group 3), and a physical mixture of andrographolide and ferulic acid (control group 4) were prepared.
The determination method comprises the following steps: adding 1mL of sample or reference solution (0.00-5.00 mg/mL) into 1mL of DPPH alcoholic solution, mixing uniformly, reacting in dark, measuring absorbance at 520nm, repeating the above experiment for 3 times, and averaging
Wherein A isoIs the light absorption value of 1mL of DPPH alcoholic solution plus 1mL of water; a. theiIs the light absorption value of 1mL of DPPH alcoholic solution plus 1mL of sample solution;Ajthe absorbance was measured after mixing 1mL of the sample solution with 1mL of ultrapure water.
TABLE 1 assay of DPPH radical scavenging Activity of derivatives of the invention
Test results show that compared with a control group, the derivative of the invention has obvious antioxidant activity, and the DPPH free radical clearance rate reaches 94.22% under the same concentration, which indicates that the compound prepared by the invention has good antioxidant activity; in the other three control groups, except vitamin C, the antioxidant activity of the physical mixture group of andrographolide and asafetida is the lowest, which indicates that the two antioxidants cannot obtain obvious antioxidant performance by simple physical mixing, and the two compounds need to be combined through chemical bonds to improve the antioxidant performance of the substances in a synergistic manner, so that the usage amount of the antioxidants is reduced.
Claims (4)
2. a preparation method of ferulic acid derivatives with antioxidant activity is characterized by comprising the following steps:
(1) dissolving andrographolide in an anhydrous organic solvent A, slowly adding oxalyl chloride at the temperature of-10-0 ℃, adding 2-3 drops of DMF (N, N-dimethylformamide), raising the temperature to react for 2-5 h, and removing the oxalyl chloride after the reaction is finished;
(2) and (2) dissolving the product obtained in the step (1) in an organic solvent B, adding ferulic acid, stirring at room temperature for reaction for 4-8 h, and displaying no progress of the reaction by thin-layer chromatography. Adding sodium bicarbonate solution into the reaction solution, extracting with dichloromethane or ethyl acetate, washing the organic phase with saturated saline solution and 5% hydrochloric acid solution in sequence, drying, concentrating, and purifying the crude product by silica gel column chromatography to obtain andrographolide derivatives;
in the step (1), the organic A is dichloromethane, diethyl ether, tetrahydrofuran, benzene and toluene;
the mass/volume ratio of the andrographolide to the organic solvent A is 1: 3-5 g/mL;
the feeding molar ratio of the andrographolide to the oxalyl chloride is 1: 3-7;
the reaction temperature is 40-80 ℃.
In the step (2), the dosage of the ferulic acid is 50-70% of the dosage of the compound 1;
the solvent B is chloroform, acetone, dioxane, a mixed solvent of chloroform and acetone in a volume ratio of 1:1 or a mixed solvent of chloroform and dioxane in a volume ratio of 1: 1;
the filler of the chromatographic column in the silica gel column chromatography is 100-400 meshes of silica gel; the mass ratio of the crude product sample to the silica gel is 1: 20-50; adopting a wet method for sample loading, and dissolving the crude product sample in a low-polarity solvent selected from ether, petroleum ether or n-hexane to obtain a loaded sample;
the eluent is a mixed solution of n-hexane and ethyl acetate, and the volume ratio of the n-hexane to the ethyl acetate is 5: 1-10: 1.
3. The method of claim 2, comprising the steps of:
(1) adding 20g of andrographolide into 60mL of anhydrous dichloromethane, refluxing and dissolving for 30min, slowly adding 21.7g of oxalyl chloride at the temperature of-10-0 ℃, stirring for 30min, adding 2-3 drops of DMF (N, N-dimethylformamide), raising the temperature to 40 ℃, reacting for 2h, and removing the redundant oxalyl chloride by rotary evaporation after the reaction is finished.
(2) Dissolving 15g of the compound 1 in 100mL of chloroform, adding 7.5g of ferulic acid, stirring at room temperature for reaction for 4h, wherein thin-layer chromatography shows that the reaction does not progress, adding a sodium bicarbonate solution into a reaction solution, extracting with dichloromethane (3X 0.5L), washing an organic phase with a saturated saline solution and a 5% hydrochloric acid solution in sequence, drying with anhydrous sodium sulfate, and concentrating to obtain a crude product; dissolving the crude product with low-polarity ether, stirring the crude product with 100-400-mesh silica gel to obtain a sample, wherein the mass ratio of the crude product to the silica gel is 1:20, separating and purifying the sample on the silica gel column, eluting impurities with an eluant consisting of n-hexane and ethyl acetate according to the volume ratio of 5:1, collecting the eluant, and concentrating to obtain the andrographolide derivative.
4. The use of the derivative of claim in an antioxidant agent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110402623.1A CN113173896A (en) | 2021-04-14 | 2021-04-14 | Ferulic acid derivative with antioxidant activity and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110402623.1A CN113173896A (en) | 2021-04-14 | 2021-04-14 | Ferulic acid derivative with antioxidant activity and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113173896A true CN113173896A (en) | 2021-07-27 |
Family
ID=76923622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110402623.1A Withdrawn CN113173896A (en) | 2021-04-14 | 2021-04-14 | Ferulic acid derivative with antioxidant activity and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113173896A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001085710A1 (en) * | 2000-05-05 | 2001-11-15 | Dr. Reddy's Research Foundation | Novel anticancer compounds: process for their preparation and pharmaceutical compositions containing them |
CN102260173A (en) * | 2009-08-14 | 2011-11-30 | 上海金昊药业开发有限公司 | Ferulic acid derivative of Glaucocalyxin A, its preparation method and its application |
CN109232253A (en) * | 2018-10-23 | 2019-01-18 | 宜宾五粮液股份有限公司 | The preparation method of ferulic acid saturated fat diester |
-
2021
- 2021-04-14 CN CN202110402623.1A patent/CN113173896A/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001085710A1 (en) * | 2000-05-05 | 2001-11-15 | Dr. Reddy's Research Foundation | Novel anticancer compounds: process for their preparation and pharmaceutical compositions containing them |
CN102260173A (en) * | 2009-08-14 | 2011-11-30 | 上海金昊药业开发有限公司 | Ferulic acid derivative of Glaucocalyxin A, its preparation method and its application |
CN109232253A (en) * | 2018-10-23 | 2019-01-18 | 宜宾五粮液股份有限公司 | The preparation method of ferulic acid saturated fat diester |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wu et al. | Preparation and stability investigation of the inclusion complex of sulforaphane with hydroxypropyl-β-cyclodextrin | |
Shuang et al. | Preparation of a stilbene diamido-bridged bis (β-cyclodextrin)-bonded chiral stationary phase for enantioseparations of drugs and pesticides by high performance liquid chromatography | |
CN110013836B (en) | Reversed phase/ion exchange mixed mode chromatographic stationary phase, preparation method and application | |
CN113173896A (en) | Ferulic acid derivative with antioxidant activity and preparation method thereof | |
CN111560044B (en) | 11-O-momordica grosvenori alcohol oxime ether derivative and preparation method thereof | |
CN111103375B (en) | Application of chlorogenic acid derivative in medicine quality control | |
CN107540686B (en) | A kind of coumarin kind compound containing benzofuran ring, preparation method and applications | |
CN104628531A (en) | Compound SJ-11 extracted from lindera reflexa hemsl as well as preparation method and application of compound SJ-11 | |
CN102329355B (en) | The preparation method of a kind of Myricitroside and pharmaceutical composition thereof | |
CN109134581A (en) | Three water dexamethasone sodium phosphate compounds of one kind and its drug combination preparation | |
CN105218645A (en) | A kind of Caspofungin impurity C of high-purity high-yield 0preparation method | |
CN104027815A (en) | Tanshinone inclusion fluid as well as preparation method and application thereof | |
CN112083044B (en) | Multiple hydrogen bond organic supramolecular nanorod/graphene oxide compound and preparation method and application thereof | |
CN103396408A (en) | Preparation method of impurity B in candesartan cilexetil | |
CN110256217B (en) | Preparation method of o-methoxybenzaldehyde | |
CN102225208A (en) | Limonene inclusion complex and preparation method thereof | |
CN105732702A (en) | Hydrogenated soybean lecithin and preparation method and application thereof | |
CN105175352A (en) | Preparation method of nitazoxanide | |
CN101735172A (en) | Cinepazide monohydrate, crystal forms and preparation method thereof | |
CN113069554B (en) | Preparation method and application of oleanolic acid quaternary ammonium salt-heparin-chitosan nanoparticles | |
CN113200946A (en) | Water-soluble antioxidant and preparation method thereof | |
CN108250244B (en) | Bismuth bitartrate-beta-cyclic lactone compound, preparation method thereof, pharmaceutical composition thereof and application thereof | |
CN105168223A (en) | Anti-bacterial medicine-ceftezole sodium composition | |
CN106008636B (en) | Tc 99m labelled glucose dithiocarbamate complexes and preparation method and application | |
CN113620914A (en) | Andrographolide derivative and industrial chromatographic preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20210727 |